NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jun 8, 2023 $1.86 -95.08% $1.74 V 93.10% 1
Jun 8, 2023 $1.83 -95.16% $1.74 V 94.75% 1
Jun 8, 2023 $1.85 -95.10% $1.74 V 93.49% 1
Jun 8, 2023 Bullish $1.74 X 0
JS JS Pro
Jun 7, 2023 $1.77 -95.06% $1.89 V 93.65% 0
JS JS Pro
Mar 9, 2022 $1.82 -95.08% $1.82 V 100.00% 10
Mar 9, 2022 $1.91 -94.84% $1.82 X 95.05% 0
JS JS Pro
Apr 28, 2021 $2.17 -95.30% $2.31 V 93.94% 0
JS JS Pro
Apr 6, 2021 $2.33 -94.73% $2.21 X 94.57% 0
Mar 5, 2021 Bullish $1.82 X 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE